Guanidine compounds
US5494934A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 4, 1991 |
| Grant date | Feb 27, 1996 |
| Priority date | — |
| Expiry date | Nov 4, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I): ##STR1## in which: R.sub.1 represents substituted or unsubstituted phenyl or (C.sub.3 -C.sub.7) cycloalkyl, PA1 R.sub.2 represents trifluoromethyl or (C.sub.3 -C.sub.4) cycloalkyl, PA1 A represents --CH.sub.2 --, --CH.dbd.N--, .dbd.N-- or --NH--, PA1 R.sub.3 and R.sub.4, which may be identical or different, represent hydrogen or linear or branched (C.sub.1 -C.sub.6) alkyl or, with the nitrogen atoms to which they are attached, form a 5- or 6-membered heterocycle, PA1 R represents either hydrogen in the case where A=--CH.sub.2 --, --CH.dbd.N-- or --NH--, or a bond of the group A when the latter is equal to .dbd.N--, its enantiomers and epimers as well as its addition salts with a pharmaceutically acceptable acid. Medicine products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.